IFN-γ Inhibits Thrombin- and Endotoxin-Induced Plasminogen Activator Inhibitor Type 1 in Human Endothelial Cells

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2610-2617

  Gallicchio, Marisa ^a   Hufnagl, Peter ^b   Wojta, Johann ^b   Tipping, Peter ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITOR; THROMBIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; HUMAN; METABOLISM; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; ENDOTOXINS; HUMANS; INTERFERON TYPE II; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITORS; THROMBIN;

EID: 0030587084     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Pober, J. S., and R. S. Cotran. 1990. The role of endothelial cells in inflammation. Transplantation 50:537.
2. Vassalli, J-D., A-P. Sappino, and D. Belin. 1991. The plasminogen activator/ plasmin system. J. Clin. Invest. 88:1067.
3. Loskutoff, D. J. 1991. Regulation of PAI-1 gene expression. Fibrinolysis 5:197.
4. Wojta, J., M. Gallicchio, H. Zoellner, E. L. Filonzi, J. A. Hamilton, and K. McGrath. 1993. Interleukin-4 stimulates expression of urokinase-type plasminogen activator in cultured human foreskin microvascular EC. Blood 81:3285.
5. Hansson, G. K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169.
6. Nykjaer, A., B. Moller, R. F. Todd, T. Christensen, P. A. Andreasen, J. Gliemann, and C. M. Peterson. 1994. Utokinase receptor: an activation antigen in human T lymphocytes. J. Immunol. 152:505.
7. Kirchheimer, J. C., Y-H. Nong, and H. G. Remold. 1988. IFN-γ, tumor necrosis factor-α and urokinase regulate the expression of urokinase receptors on human monocytes. J. Immunol. 141:4229.
8. Doukas, J., and J. S. Pober. 1990. IFN-γ enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145:1727.
9. Zuckerman, S. H., and Y. M. Surpreant. 1986. Induction of endothelial cell/ macrophage procoagulant activity: synergistic stimulation by gamma interferon and granulocyte-macrophage colony stimulating factor. Thromb. Haemost. 61: 178.
10. Schneiderman, J., M. S. Sawdey, M. R. Keeton, G. M. Bordin, E. F. Berstein, R. B. Dilley, and D. J. Loskutoff. 1992. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 89:6998.
11. Gimbrone, M. A., R. Cotran, and J. J. Folkman. 1974. Human vascular endothelial cells in culture, growth and DNA synthesis. J. Cell Biol. 60:673.
12. Gospodarowicz, D. 1975. Purification of a fibroblast growth factor from bovine pituitary. J. Biol. Chem. 250:2515.
13. Wojta, J., M. Holzer, P. Hufnagl, G. Christ, R. L. Hoover, and B. R. Binder. 1991. Hyperthermia stimulates plasminogen activator inhibitor type 1 (PAI-1) expression in human umbilical vein endothelial cells (HUVEC) in vitro. Am. J. Pathol. 139:911.
14. Chirgwin, J. M., A. E. Przybyala, R. J. McDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
15. Collins, T., L. A. Lapierre, W. Fiers, J. L. Strominger, and J. S. Pober. 1986. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular EC and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 83:446.
16. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917.
17. Zuckerman, S. H., and Y. M. Surpreant. 1986. Induction of endothelial cell/ macrophage procoagulant activity: synergistic stimulation by gamma interferon and granulocyte-macrophage colony stimulating factor. Thromb. Haemost. 61: 178.
18. Doukas, J., and J. S. Pober. 1990. IFN-γ enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145:1727.
19. Niedbala, M. J., and M. S. Picarella. 1992. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and ils antagonism by γ-interferon. Blood 79:678.
20. Wojta, J., H. Zoellner, M. Gallicchio, J. A. Hamilton, and K. McGrath. 1992. γ-interferon counteracts interleukin-α stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem. Biophys. Res. Commun. 188:463.
21. Schleef, R. R., M. P. Bevilacqua, M. Sawdey, M. A. Gimbrone, Jr., and D. J. Loskutoff. 1988. Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem. 263:5797.
22. Van Hinsbergh, V. W. M., T. Kooistra, E. A. van den Berg, H. M. G. Princen, W. Fiers, and J. J. Emeis. 1988. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 72:1467.
23. Smith, T. J., A. Ahmed, M. G. Hogg, and P. J. Higgins. 1992. Interferon-γ is an inducer of plasminogen activator inhibitor type 1 in human orbital fibroblasts. Am. J. Physiol 263:C24.
24. Pugin, J., C-C. Schurer-Maly, D. Leturq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Prof. Natl. Acad. Sci. USA 90:2744.
25. Konkle, B. A., and D. Ginsburg. 1988. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. J. Clin. Invest. 82:579.
26. Minter, A. J., J. Dawes, and C. N. Chesterman. 1992. Effects of heparin and endothelial cell growth supplement and haemostatic functions of vascular endothelium. Thromb. Haemost. 67:718.
27. Friesel, R., A. Komoriya, and T. Maciag. 1987. Inhibition of endothelial cell proliferation by gamma interferon. J. Cell Biol. 226:345.
28. Christ, G., D. Seiffert, P. Hufnagl, A. Gessl, J. Wojta, and B. R. Binder. 1993. Type 1 plasminogen activator inhibitor synthesis of endothelial cells is down-regulated by smooth muscle cells. Blood 81:1277.
29. Mussoni, L., P. Maderna, M. Camera, F. Bernini, L. Sironi, M. Sirtori, and E. Tremoli. 1990. Atherogenic lipoproteins and release of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells. Fibrinolysis 4:79.
30. Shatos, M. A., J. M. Doherty, D. C. Stump, E. A. Thompson, and D. Collen. 1990. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture. J. Biol. Chem. 265:20443.
31. Yamamoto, C., T. Kaji, M. Sakamoto, and H. Kozuka. 1993. Modulation by endothelin-1 of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells: interaction of endothelin-1 with cytokines. Biol. Pharm. Bull. 16:714.
32. Yamamoto, C., T. Kaji, M. Sakamoto, and F. Koizumi. 1992. Effect of endothelin on the release of tissue plasminogen activator and plasminogen activator inhibitor-1 from cultured human endothelial cells and interaction with thrombin. Thromb. Res. 67:619.
33. Kaji, T., C. Yamamoto, M. Sakamoto, H. Kozuka, and F. Koizumi. 1994. Suppression of plasminogen activator inhibitor type 1 release from cultured human umbilical vein endothelial cells by basic fibroblast growth factor. Life Sci. 54: 1563.
34. Van Hinsbergh, V. W. M., M. Vermeer, P. Koolwijk, J. Grimbergen, and T. Kooistra. 1994. Genistein reduces tumor necrosis factor-α-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood 9:2984.
35. Emeis, J. J., R. Hoekzema, and A. P. de Vos. 1995. Inhibiting interleukin-1 and tumor necrosis factor-α does not reduce plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood 85:115.
36. Gelehrter, T. D., and R. Sznycer-Laszuk. 1986. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J. Clin. Invest. 77: 165.
37. Grulich-Henn, J., and G. Z. Muller-Berghaus. 1990. Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester and thrombin. Blut 61:38.
38. Santell, L., and E. G. Levin. 1988. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. J. Biol. Chem. 263: 16802.
39. Francis, R. B., and S. Neely. 1989. Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP. Biochim. Biophys. Acta 1012:207.
40. Slivka, S. R., and D. J. Loskutoff. 1991. Regulation of type 1 plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim. Biophys. Acta 1094:317.
41. Fattal, P. G., D. J. Schneider, B. E. Sobel, and J. J. Billadello. 1992. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J. Biol. Chem. 267:12412.
42. Siren, V., I. Immonen, K. Cantell, and A. Vaheri. 1994. Alpha- and gamma-interferon inhibit plasminogen activator inhibitor-1 gene expression in human retinal pigment epithelial cells. Ophthalmic Res. 26:1.
43. Jonasson, L., J. Holm, O. Skalli, G. Bonjers, and G. K. Hansson. 1986. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131.
44. Hruban, R. H., W. E. Beschorner, W. A. Baumgartner, S. M. Augustine, H. Ren, B. A. Reitz, and G. M. Hutchins. 1990. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am. J. Pathol. 137:871.
45. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801.
46. Loskutoff, D. J., M. Sawdey, M. Keeton, and J. Schneiderman. 1993. Regulation of PAI-1 gene expression in vivo. Thromb Haemost. 70:135.
47. Quax, P. H. A., M. van den Hoogen, J. H. Verheijen, T. Padro, R. Zeheb, T. D. Gelehrter, T. S. van Berkel, J. Kuiper, and J. J. Emeis. 1990. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J. Biol. Chem. 265:15560.
48. Gluszko, P., A. Undas, S. Amenta, A. Szczeklik, and A. H. Schmaier. 1994. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor. J. Lab. Clin. Med. 123:232.
49. Libby, P. 1995. Molecular basis of the acute coronary syndromes. Circulation 91:2844.